Screening for Disease Dr Meenakshi Khapre.

Slides:



Advertisements
Similar presentations
Extent of Problem 66,000 adults & children in NI with diabetes Estimates of ca 12,500 people who are as yet unaware that they have the condition.
Advertisements

Quality Management in Diagnostic Imaging
Validity and Reliability of Analytical Tests. Analytical Tests include both: Screening Tests Diagnostic Tests.
Diagnostic Method Diagnosis Diagnosis means `through knowledge` and entails acquisition of data about the patient and their complaints using the senses:
SCREENING FOR DISEASE Nigel Paneth. THREE KEY MEASURES OF VALIDITY 1.SENSITIVITY 2.SPECIFICITY 3.PREDICTIVE VALUE.
EPIDEMIOLOGY AND BIOSTATISTICS DEPT Esimating Population Value with Hypothesis Testing.
1 Comunicación y Gerencia 18/4/2011Dr Salwa Tayel (Screening) بسم الله الرحمن الرحيم.
Screening. Screening refers to the application of a test to people who are as yet asymptomatic for the purpose of classifying them with respect to their.
Principles of Epidemiology Lecture 12 Dona Schneider, PhD, MPH, FACE
Screening for Disease Guan Peng Department of Epidemiology School of Public Health, CMU.
Screening Manish Chaudhary BPH(IOM), MPH(BPKIHS)
Screening and Early Detection Epidemiological Basis for Disease Control – Fall 2001 Joel L. Weissfeld, M.D. M.P.H.
What is Screening? Basic Public Health Concepts Sheila West, Ph.D. El Maghraby Professor of Ophthalmology Wilmer Eye Institute Johns Hopkins University.
SCREENING FOR DISEASE -2
The Nature of Disease.
Multiple Choice Questions for discussion
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
EPIB-591 Screening Jean-François Boivin 29 September
Screening Introduction to Primary Care:
SCREENING Asst. Prof. Sumattna Glangkarn RN, MSc. (Epidemiology), PhD (Nursing studies)
Reliability of Screening Tests RELIABILITY: The extent to which the screening test will produce the same or very similar results each time it is administered.
Saudi Diploma in Family Medicine / 24 1 Dr. Zekeriya Aktürk Preventive Medicine and Periodic Health Examinations in Primary Care.
Dr K N Prasad Community Medicine
Screening and Diagnostic Testing Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego State University.
1 SCREENING. 2 Why screen? Who wants to screen? n Doctors n Labs n Hospitals n Drug companies n Public n Who doesn’t ?
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
Ann Jolly1 Screening “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...” “...sort.
· Lecture 31 & 32 : Scope of clinical biochemistry ط Uses of clinical biochemistry tests ط Diagnosis, Prognosis, Screening, Monitoring ط Reporting results.
Screening Puja Myles
SCREENING Dr. Aliya Hisam Community Medicine Dept. Army Medical College, RWP.
Evaluating Screening Programs Dr. Jørn Olsen Epi 200B January 19, 2010.
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
SCREENING TTTThe search for unrecognized disease or defect by means of rapidly applied tests, examinations or other procedures in apparently healthy.
Principles of Screening
Screening and its Useful Tools Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
Diagnostic Tests Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /7/20151.
1 Wrap up SCREENING TESTS. 2 Screening test The basic tool of a screening program easy to use, rapid and inexpensive. 1.2.
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Screening.  “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...”  “...sort out.
12/12/2009Dr. Salwa Tayel1 Comunicación y Gerencia.
SCREENING FOR DISEASE. Learning Objectives Definition of screening; Principles of Screening.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
SCREENING FOR DISEASE-1
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
دکتر حمیدرضا صابری
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
Screening System for Hypertension and Diabetes at Primary Care Level
DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M
Cancer prevention and early detection
Clinical Epidemiology
Diagnostic Test Studies
بسم الله الرحمن الرحيم.
Evidence Based Screening
Principles of Epidemiology E
Diffusion of Innovation
Class session 7 Screening, validity, reliability
Understanding Results
Dr. Tauseef Ismail Assistant Professor Dept of C Med. KGMC
Comunicación y Gerencia
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
How do we delay disease progress once it has started?
Breast Cancer SKRINING
Prevention 11/20/2018.
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
Screening, Sensitivity, Specificity, and ROC curves
Dr. Hannah Jordan Lecturer in Public Health ScHARR
Review – First Exam Chapters 1 through 5
Public Health Surveillance
No matter what the type of genetic screening, certain core principles should be followed before a program is introduced. Principles of Screening • The.
Presentation transcript:

Screening for Disease Dr Meenakshi Khapre

Iceberg Phenomenon

Concept of Lead Time “LEAD TIME” It is the period between diagnosis by early detection and diagnosis by other means. Detection programmes should be restricted to those conditions in which there is considerable time lag between disease onset and the usual time of diagnosis.

Screening for disease “Screening is the search for unrecognized disease or defect by means of rapidly applied tests, examinations or other procedures in apparently healthy individuals.” “Screening includes methods; technique; procedure and examinations for early and rapid detection of unrecognized disease or defect in apparently healthy persons.” A screening program tests people for a disease or condition before they have symptoms of the disease.

Definitions of screening have been changing with time & they range from simplest to most complicated ones, one of which defines it as ‘It is a medical investigation which doesn’t arise from patient’s request for advice for a specific complaints’ while the latest one by National Screening Committee 2nd report(2000) is ‘Screening is a public health service in which members of a defined population who do not necessarily perceive that they are at risk of or are already affected by a disease or it’s complications are asked a question or offered a test to identify those individuals who are more likely to be helped than harmed by further tests or treatment to reduce the risk of disease or it’s complications’ ... Contd.

Historical background The benefits of screening were 1st introduce by the use of mass miniature radiography (MMR) for the identification of individual with TB. With the introduction of effective treatment for this condition after the second word war. The use of MMR became widespread in many western countries particularly with USA and UK. In the late 1950’s and early 1960’s special campaign of mass radiography were used to good effect in Scotland 1st in Glasgow and then throughout the country to try and find unknown and infection sufferer from TB.

Screening is carried out in the hope that earlier diagnosis and subsequent treatment favorably alters the natural history of the disease in significant proportion of those who are identified as “positive” The goal of this program is to discover conditions in there earliest and most treatable stages. The program only works for certain conditions where there is effective treatment, and effective and sensitive screening tests. In these cases, minimally invasive treatments can be used, and improved life expectancy should result. 1 Control of disease 2 Researches 3 Early diagnoses 4 Educational Purposes For What it is done? Objectives

Case detection Also known as ‘Prescriptive screening’ it is defined as presumptive identification of unrecognized disease which doesn't from patient’s request. Control of disease Also known as ‘prospective screening’ ie people are examined for benefit of others. Research purposes Screening may aid in obtaining basic knowledge about natural history of diseases whose etiology/pathogenesis is obscure. Educational opportunities Helpful in creating public awareness & educating health professionals. Uses

Types Mass Screening It is screening of whole population or a sub group It has gone out of use nowadays. High Risk / Selective Screening It is most productive because it is applied to selectively to the high risk group on the basis of epidemiological research Multi Phasic Screening It is application of two or more screening tests in combination to large no. of people at one time than to carry out separate screening tests for single disease

Cont… Multipurpose screening Opportunistic screening

Screening tests Diagnostic tests Done on those with indication or sick. Applied on single patient, all diseases are consider. Diagnosis is not final but modified in light of new evidence, diagnosis is sum of all evidence. Based on evaluation of a number of symptoms, sign and lab findings. More accurate. More expensive. Used as a basis for treatment. Done on apparently healthy. Applied on groups. Test results are arbitrary and final. Based on one criteria or cut-off point . Less accurate. Less expensive. Not basis for treatment.

CRITERIA for screening for diseases Criteria acceptable, and safe screening tests are essential; the disease screened must be common and should have a detectable preclinical stage, for which effective treatment should be available; a large proportion of people at risk should participate in screening, investigations and treatment; the local health services infrastructure should be sufficiently developed to provide the diagnostic, treatment and follow-up services.

Consideration for criteria Diseases to be screened The tests to be applied

Diseases to be screened should fulfill the following criteria The condition sought Latent or early asymptomatic stage The natural history of condition Facilites available to confirm diagnosis Effective treatment Policy to treat Early detection & treatment reduces morbidity & mortality.

Screening tests to be applied The test must satisfy the criteria of acceptability, repeatability, validity besides others like yield,simplicity, safety,rapidity,ease of adsministration & of cost.

1.Acceptability 2.Reapeatability Screening test 1.Acceptability The test should be acceptible to all the peoples at whom it is aimed. 2.Reapeatability The test must give consistent results when repeated more than once on same individual or material under same condition.It depends upon 3 major factors.

3 factors on which repeatability depends upon are 1.Observer variation Screening test 3 factors on which repeatability depends upon are 1.Observer variation (a)Intra observer variation (b)Inter observer variation 2.Biological variation 3.Errors related to technical methods

All observations are subjected to variation. Repeatability 1.OBSERVER VARIATION All observations are subjected to variation. If a single observer takes 2 measurements in the same subject,at the same time & each time,he obtained a different result it is termed as intra-observer variation. The variation between different observers on the same subject or material is called inter-observer variation.

3.errors related to technical methods Repeatability 2.Biological variation It is assotiated with physiologic variables such as blood pressure,blood sugar etc. Fluctuation is due to changes in the parameters obs,variations in the way the patient percive their sympt & ans & regression to the mean. 3.errors related to technical methods Repeatability may be affected by variations inherent in the methods.

Screening test 3.validity It refers to what extent the test accurately measures which it purports to measure. Eg: glycosuria is a useful test for screening for diabetes,but a more valid test is the glucose tolerence test. It has two components sensitivity & specificity.

Evaluation of Screening Tests

Evaluation of screening tests Following measures are used to evaluate a screening test : Sensitivity Specificity Predictive value of a positive test Predictive value of a negative test Percentage of false negative Percentage of false positive

Sensitivity Specificity Predictive accuracy The term was introduced by Yerushalmy in 1940’s. it is define as the ability of a test to identify correctly all those who have the disease. i.e. true positive. Specificity It is define as the ability of a test to identify correctly those who do not have disease i.e. “true negative”. Predictive accuracy It reflects diagnostic power of the test. Predictive value of a positive test reflects the probability that a patient with a positive test result has in fact the disease in question. The more prevalent a disease is in a given population, the more accurate will be the predictive value of a positive screening test .

False negatives & False positives The term false negatives means that the patient who actually have the disease are told that they do not have the disease. It amounts to giving them false reassurance. False positives It means that patients who do not have the disease they are told they have. In this case normal people are subjected to further investigations at some inconvenience, discomfort, anxiety & expense. They not only are burden to diagnostic facilities but they also bring discredit to screening programme

Summary of criteria for evaluation of screening Factors Simplicity Acceptibility Accuracy Cost Repeatability Sensitivity Specificity Criteria Simple to perform easy to interupt & paramedical person should be able to perform. It must be acceptable to all who are undergoing it It should give true measurements of condition or symptom Expense of test must be considered in relation of early detection of disease The test should give consistent result in repeated trials The test should be capable of giving a positive finding when individual being is screened has condition being sought Test should be capable of giving negative results when individual being screened doesn’t condition being sought

Yield Combination of tests It is the amount of previously unrecognized disease that is diagnosed as a result of the screening efforts. It depends upon many factors – Sensitivity & specificity of the test, prevalence of the disease, the participation of individuals in the detection programme. Hence to enhance the yield high risk population are usually selected. Higher the Yield, higher is the efficiency of screening programme. Combination of tests Two or more tests can used in combination in order to enhance the efficiency of screening

The Problem Of Borderline The question arises which of the two qualities (sensitivity or specificity) is more important in screening? (a) Bimodal distribution.The two curves overlap.The shaded area will comprise a mixture of persons with diseases & persons without diseases. (b) Unimodal distribution.No line dividing between the “normal” & “diseased”.

Decision Making Prior decision is made about the cut-off point. The following factors are taken into consideration. (a) DISEASE PREVALENCE: When the prevalence is high in the community,the screening level is set at a lower level. (b) THE DISEASE: IF the disease is very lethal (e.g;cervical cancer,breast cancer) and early detection markedly improves